Exploratory Changes in Surfactant Protein D During Intermittent Hypoxia and Modulation by Galectin-3 Inhibition
Advances in Respiratory Medicine · 24.04.2026 · 94 (3) · 27
DOI: 10.3390/arm94030027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 24.04.2026. Verfasst von Saad Al-Anazi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia. Hauptthemen laut MEDLINE: Pulmonary Surfactant-Associated Protein D, Galectin 3, Hypoxia, Pectins. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Background
Surfactant Protein D (SP-D) is a critical immunomodulatory collectin maintaining alveolar homeostasis. Obstructive sleep apnea (OSA)-related intermittent hypoxia (IH) disrupts pulmonary surfactant integrity; however, severity-dependent SP-D dynamics remain incompletely characterized. This study explores SP-D as a potential indicator of IH-induced alveolar stress and evaluates whether Galectin-3 (Gal-3) inhibition modulates surfactant homeostasis.
Methods
Forty adult male Sprague-Dawley rats (8 per group) were randomized to Control (normoxia), Moderate IH (MIH; 15–30 events/hour), Severe IH (SIH; 30–60 events/hour), MIH + Gal-3 inhibitor (Modified Citrus Pectin, 800 mg/kg/day), or SIH + Gal-3 inhibitor. IH exposure lasted 8 h/day for 10 days. Outcomes included circulating SP-D, Surfactant Protein B (SP-B), inflammatory markers, physiological parameters, and histopathological lung injury scores assessed via American Thoracic Society guidelines.
Results
SP-D levels showed numerical reductions with increasing IH severity (Control: 1969.07 pg/mL [IQR: 262.15]; SIH: 1404.30 pg/mL [IQR: 351.88]), representing a 28.6% decrease. However, between-group variability resulted in non-significant omnibus testing (Kruskal–Wallis p = 0.187). Gal-3 inhibition elevated SP-D levels, particularly in severe IH (2133.95 pg/mL [IQR: 1240.70]), though high inter-individual variability was observed (CV = 58.1%). SP-B showed significant suppression under moderate IH (p = 0.019) with restoration by treatment. Exploratory correlation analysis revealed moderate positive associations between SP-D and heart rate (r = 0.587) and respiratory rate (r = 0.419) in severe IH, though these did not reach statistical significance (p = 0.126 and p = 0.301, respectively). Histologically, severe IH induced diffuse alveolar damage (total lung score: 19.67 ± 0.82). Gal-3 inhibition produced context-dependent effects: protective in severe IH but paradoxically exacerbating inflammation under moderate IH (29.20 ± 4.64 vs. 20.00 ± 4.34; p < 0.05). Gal-3 inhibition significantly attenuated cardiac injury (injury score: 0.00 ± 0.00 vs. 7.17 ± 0.75 in severe IH; p < 0.001, η2 = 0.859).
Conclusions
SP-D demonstrates severity-associated alterations consistent with alveolar epithelial stress during IH, though high variability limits definitive biomarker validation in this sample. Gal-3 inhibition modulates surfactant homeostasis and attenuates cardiopulmonary injury in a context-dependent manner. These findings support further investigation into SP-D as a component of multimodal severity stratification in OSA and highlight Gal-3 inhibition as a context-dependent anti-inflammatory strategy, pending validation in larger cohorts with tissue-level confirmation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
- Azeer Medical Company, Jeddah 21382, Saudi Arabia.
- Experimental Surgery and Animal Laboratory, Prince Naif for Health Research Center (PNHRC), College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.
- Histopathology Unit, Department of Pathology, College of Medicine, King Saud University Medical City, Riyadh 11472, Saudi Arabia.
ORCID-Profile: Saad Al-Anazi, Syed Shahid Habib
Förderung
- King Saud University
Zitieren
APA
Al-Anazi, S., Alshawakir, Y. A., Habib, S. S., Gad, H., Alotaibi, A. F., Aljasham, A. T., Althakfi, W. A., Mekhtiche, M. A., & Al-Masri, A. A. (2026). Exploratory Changes in Surfactant Protein D During Intermittent Hypoxia and Modulation by Galectin-3 Inhibition. Advances in Respiratory Medicine, 94(3), 27. https://doi.org/10.3390/arm94030027
Vancouver
Al-Anazi S, Alshawakir YA, Habib SS, Gad H, Alotaibi AF, Aljasham AT, et al. Exploratory Changes in Surfactant Protein D During Intermittent Hypoxia and Modulation by Galectin-3 Inhibition. Advances in Respiratory Medicine. 2026;94(3):27. doi:10.3390/arm94030027
BibTeX
@article{AlAnazi2026,
author = {Al-Anazi, Saad and Alshawakir, Yasser A and Habib, Syed Shahid and Gad, Hayam and Alotaibi, Asma F and Aljasham, Alanoud T and Althakfi, Wajd Ahmed and Mekhtiche, Mohamed A and Al-Masri, Abeer Abdulmoati},
title = {Exploratory Changes in Surfactant Protein D During Intermittent Hypoxia and Modulation by Galectin-3 Inhibition},
journal = {Advances in Respiratory Medicine},
year = {2026},
volume = {94},
number = {3},
pages = {27},
doi = {10.3390/arm94030027}
}
EUVIMED